Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)

Fig. 4

The prognostic performance of the 7-gene prognostic signature in the validation group. a Kaplan–Meier survival analysis of the seven-gene prognostic signature. b The receiver operating characteristic (ROC) curve analysis of seven-gene prognostic signature. c The distribution of risk scores (upper panel), the distribution of survival time (middle panel), and seven-gene expression profiles (bottom panel). Black dotted lines (median risk score) divide patients into low- and high-risk groups. Patients in the high-risk group are represented by red lines and dots. Patients in the low-risk group are represented by green lines and dots. AUC area under the curve, RIMS2 Regulating Synaptic Membrane Exocytosis 2, UCN2 Urocortin 2, PGM5 Phosphoglucomutases, CAVIN2 Caveolae Associated Protein 2, CLIC6 Chloride Intracellular Channel 6, GRIA1 Glutamate Ionotropic Receptor AMPA Type Subunit 1, PKHD1L1 Polycystic Kidney and Hepatic Disease 1-Like 1

Back to article page